Madrigal Pharmaceuticals, Inc. (MDGL)
NASDAQ: MDGL · Real-Time Price · USD
326.66
-1.21 (-0.37%)
Mar 31, 2025, 1:14 PM EDT - Market open
Madrigal Pharmaceuticals Analyst Ratings
Total Analysts
10
Consensus Rating
Buy
Price Target
$354.75
Upside
+8.60%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Buy Maintains $378 → $469 | Strong Buy | Maintains | $378 → $469 | +43.57% | Feb 27, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $400 → $405 | Strong Buy | Maintains | $400 → $405 | +23.98% | Feb 27, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $390 → $400 | Strong Buy | Maintains | $390 → $400 | +22.45% | Jan 14, 2025 |
| JMP Securities | JMP Securities | Buy Reiterates $427 | Buy | Reiterates | $427 | +30.72% | Jan 10, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Nov 20, 2024 |
| B. Riley Securities | B. Riley Securities | Hold Maintains $194 → $236 | Hold | Maintains | $194 → $236 | -27.75% | Nov 5, 2024 |
| UBS | UBS | Strong Buy Maintains $411 → $441 | Strong Buy | Maintains | $411 → $441 | +35.00% | Nov 1, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $375 → $350 | Buy | Maintains | $375 → $350 | +7.15% | Oct 23, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $390 | Strong Buy | Reiterates | $390 | +19.39% | Oct 22, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Oct 11, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $382 → $371 | Strong Buy | Maintains | $382 → $371 | +13.57% | Aug 8, 2024 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $405 → $360 | Buy | Maintains | $405 → $360 | +10.21% | Aug 8, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Jul 23, 2024 |
| JMP Securities | JMP Securities | Buy Maintains $381 → $385 | Buy | Maintains | $381 → $385 | +17.86% | Jul 16, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Jun 28, 2024 |
| Wolfe Research | Wolfe Research | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Jun 11, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.